CASC3 and Miyoshi myopathy: Regarding the findings that BTZ could downregulate miR-21 [8] or miR-27a [29] in MM cells, involvement of at least these miRNAs in MM drug resistance sounds counterintuitive as it may be expected that the drug should not modulate the miRNAs.